Reclimet Tablet (14) is a commercial drug that is prescribed in the form of Tablet. Primarily, it is used for the treatment of Diabetes. Secondary and off-label uses of Reclimet Tablet (14) have also been mentioned below.
The optimal dosage of Reclimet Tablet (14) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Reclimet Tablet (14) also has some side effects, the most common being Nausea or vomiting, Bradycardia, Constipation. Apart from the aforementioned side effects, Reclimet Tablet (14) can also lead to other problems, which have been listed below. Normally, these side effects of Reclimet Tablet (14) are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Reclimet Tablet (14) has a Moderate effect for pregnant women and Safe effect on lactating mothers. Warnings related to Reclimet Tablet (14)'s effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Reclimet Tablet (14) have been discussed in the sections ahead.
Drug interactions for Reclimet Tablet (14) have been reported in the medical literature. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Reclimet Tablet (14) is considered safe while driving, and is addictive.
Reclimet Tablet (14) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Based on research, the following side effects have been observed when Reclimet Tablet (14) is used -
Severe
Common
Is the use of Reclimet Tablet (14) safe for pregnant women?
Reclimet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Reclimet right away. Take your doctor's advice before taking it again.
Is the use of Reclimet Tablet (14) safe during breastfeeding?
Reclimet is completely safe for breastfeeding women.
What is the effect of Reclimet Tablet (14) on the Kidneys?
Reclimet can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Reclimet Tablet (14) on the Liver?
Reclimet may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Reclimet Tablet (14) on the Heart?
There may be severe side effects of Reclimet on your heart. Do not take it unless a doctor says so.
Reclimet Tablet (14) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Reclimet Tablet (14) unless your doctor advises you to do so -
Is this Reclimet Tablet (14) habit forming or addictive?
Reclimet Tablet (14) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Reclimet Tablet (14) as it does not make you drowsy.
Is it safe?
Yes, but consume Reclimet Tablet (14) only on doctor's advice.
Is it able to treat mental disorders?
Reclimet Tablet (14) is unable to treat or cure mental disorders.
Interaction between Food and Reclimet Tablet (14)
Taking Reclimet Tablet (14) with food does not harm your health.
Interaction between Alcohol and Reclimet Tablet (14)
Consuming Reclimet Tablet (14) with alcohol can have many serious effects on your body.
This medicine data has been created by -
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826